Clik here to view.
Praetura Ventures leads £2.9m investment in food allergy diagnostic firm
Praetura Ventures, the Manchester-based VC firm, has led a £2.9m funding round to support a business that is on course to transform the food allergy diagnostics market. Reacta Biotech (Reacta), which...
View ArticleClik here to view.
Reacta Healthcare secures first US patent
Reacta Healthcare, based in Deeside North Wales, has secured its first US patent, expanding patents already held across Europe, Australia, Canada, Hong Kong, and the UK. The patent has been granted...
View ArticleClik here to view.
Development Bank of Wales ramping up tech equity deals since the lockdown
The Development Bank of Wales has invested £2.4m of equity into ten of Wales’ most promising tech-focused start-ups over a ten week period since the pandemic lockdown. With a specialist team and...
View ArticleClik here to view.
My time at MEDICA 2022
By Dr Martin Wickham, Chief Commercial Officer, Reacta Healthcare Last month I had the privilege of not only attending but presenting at MEDICA, the world’s largest event for the medical sector. It’s...
View ArticleClik here to view.
Senior hire to cement 2023 growth plans at Reacta Healthcare
Reacta Healthcare has appointed a new quality control manager to further expand and develop its quality function. The leadership post will ensure delivery of the company’s growth plans for 2023 and...
View ArticleClik here to view.
First major milestone reached for Reacta Healthcare £1m Innovate UK funded...
Reacta Healthcare is helping combat food allergies amongst paediatrics, addressing the unmet need for greater research and clinical practice in children to prevent rising hospitalisations1, having...
View ArticleClik here to view.
New partnership with FAACT – Food Allergy & Anaphylaxis Connection Team
Reacta Healthcare is proud to partner with FAACT to support the needs of the food allergy community. FAACT’s mission is to educate, advocate, and raise awareness for all individuals and families...
View ArticleClik here to view.
Reacta Healthcare appoints Kevin Hawkins as Head of Regulatory Affairs
Reacta Healthcare appoints Kevin Hawkins as Head of Regulatory Affairs 20 June 2023, Deeside, United Kingdom: Reacta Healthcare, an early-stage food allergy diagnostic company specialising in the...
View ArticleClik here to view.
Simon Thelwall-Jones appointed as CFO
Reacta Healthcare Press Release – 23 November 2023 Reacta Healthcare bolsters Board & Executive Team with the appointment of Simon Thelwall-Jones as Chief Financial Officer. Reacta Healthcare is...
View ArticleClik here to view.
Reacta Healthcare strengthens Advisory Board in preparation for significant...
Reacta Healthcare Press Release – 30 January 2024 Reacta Healthcare is a diagnostics company based in North Wales focusing on the development, manufacture, and supply of pharmaceutical grade...
View Article